The ARPC1A Knockout HeLa Polyclonal Cells consist of a CRISPR/Cas9-edited heterogeneous population carrying targeted disruptions in the ARPC1A gene. By providing a pooled knockout model without clonal selection, this product enables robust functional assessment of ARPC1A-dependent processes while minimizing biases associated with single-cell-derived lines. The cells originate from the HeLa host cell line and are supplied as a viable, ready-to-culture knockout pool for biochemical and cell-based experimentation.
HeLa is an immortalized epithelial cell line derived from a cervical adenocarcinoma with integrated HPV18 sequences. Extensively utilized in research, HeLa cells are characterized by rapid proliferation, genetic tractability, and inherent invasive capacity, making them an optimal platform for studying actin-driven phenomena. Their epithelial nature supports investigations of cell migration, invasion, and membrane dynamics, processes tightly regulated by the Arp2/3 complex and its ARPC1A subunit.
ARPC1A encodes the p41-ARC subunit of the heptameric Arp2/3 complex, the primary nucleator of branched actin filament networks. The complex, including ARPC2?C5, ARP2, and ARP3, is activated by nucleation-promoting factors (WASp, N-WASp, WAVE) downstream of Rac1 and Cdc42 GTPases. Cortactin stabilizes branch junctions. Once activated, Arp2/3 drives F-actin polymerization, generating lamellipodial protrusions, membrane ruffles, and cell motility. ARPC1A disruption therefore impairs migration, phagocytosis, and endocytosis.
In HeLa cells, ARPC1A knockout abrogates branched actin networks, offering a powerful model for dissecting cancer cell migration and invasion. Loss of lamellipodial protrusion compromises directional movement, enabling study of HPV-related adenocarcinoma progression. The polyclonal population mirrors tumor cell heterogeneity and permits investigation of gene dosage effects and compensatory pathways. This model is also highly relevant for research into actin-associated combined immunodeficiency and autoinflammation.
These cells are compatible with standard validation techniques including Western blotting and immunofluorescence to confirm p41-ARC ablation and assess Arp2/3 complex composition. Functional assays such as wound healing, Transwell migration, and invasion assays quantify motility, while phalloidin staining reveals F-actin architecture. Co-immunoprecipitation can probe residual complex interactions. Applications encompass cytoskeletal dynamics, immune synapse formation, phagocytosis, and cancer metastasis. For technical support, please contact Ascent Research.
